Institution
Aichi Medical University
Education•Nagakute, Japan•
About: Aichi Medical University is a education organization based out in Nagakute, Japan. It is known for research contribution in the topics: Population & Transplantation. The organization has 3783 authors who have published 7857 publications receiving 156130 citations.
Topics: Population, Transplantation, Cancer, Medicine, Cohort study
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Detailed polling of transcription start and termination sites and analysis of previously unidentified full-length complementary DNAs derived from the mouse genome provide a comprehensive platform for the comparative analysis of mammalian transcriptional regulation in differentiation and development.
Abstract: This study describes comprehensive polling of transcription start and termination sites and analysis of previously unidentified full-length complementary DNAs derived from the mouse genome. We identify the 5' and 3' boundaries of 181,047 transcripts with extensive variation in transcripts arising from alternative promoter usage, splicing, and polyadenylation. There are 16,247 new mouse protein-coding transcripts, including 5154 encoding previously unidentified proteins. Genomic mapping of the transcriptome reveals transcriptional forests, with overlapping transcription on both strands, separated by deserts in which few transcripts are observed. The data provide a comprehensive platform for the comparative analysis of mammalian transcriptional regulation in differentiation and development.
3,412 citations
••
Indiana University1, University Health Network2, University Hospital Bonn3, Radboud University Nijmegen4, Cleveland Clinic5, New York University6, Jean Monnet University7, University of Chicago8, University of Queensland9, Erasmus University Rotterdam10, University of California, San Francisco11, Aichi Medical University12, University Hospital of Wales13, Cambridge University Hospitals NHS Foundation Trust14, Baylor College of Medicine15, Wayne State University16, Medical College of Wisconsin17
TL;DR: This manuscript summarizes the proceedings of the ISUP consensus meeting for grading of prostatic carcinoma held in September 2019, in Nice, France, where topics brought to consensus included approaches to reporting of Gleason patterns 4 and 5 quantities, and minor/tertiary patterns.
Abstract: Five years after the last prostatic carcinoma grading consensus conference of the International Society of Urological Pathology (ISUP), accrual of new data and modification of clinical practice require an update of current pathologic grading guidelines. This manuscript summarizes the proceedings of the ISUP consensus meeting for grading of prostatic carcinoma held in September 2019, in Nice, France. Topics brought to consensus included the following: (1) approaches to reporting of Gleason patterns 4 and 5 quantities, and minor/tertiary patterns, (2) an agreement to report the presence of invasive cribriform carcinoma, (3) an agreement to incorporate intraductal carcinoma into grading, and (4) individual versus aggregate grading of systematic and multiparametric magnetic resonance imaging-targeted biopsies. Finally, developments in the field of artificial intelligence in the grading of prostatic carcinoma and future research perspectives were discussed.
2,636 citations
••
TL;DR: The common occurrence of intracellular accumulations of TDP-43 supports the hypothesis that these disorders represent a clinicopathological entity of a single disease, and suggests that they can be newly classified as a proteinopathy of T DP-43.
2,263 citations
••
Johns Hopkins University School of Medicine1, Tufts University2, University of New South Wales3, Aarhus University Hospital4, Aarhus University5, Heidelberg University6, University of Melbourne7, Duke University8, McGill University9, University of Iowa10, Southern University of Science and Technology11, University of Toronto12, University of Washington13, Dalhousie University14, Aichi Medical University15, Queen's University16
TL;DR: This review provides a synopsis of the critical concepts, the analysis of comments from the IASP membership and public, and the committee's final recommendations for revisions to the definition and notes, which were discussed over a 2-year period.
Abstract: The current International Association for the Study of Pain (IASP) definition of pain as "An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage" was recommended by the Subcommittee on Taxonomy and adopted by the IASP Council in 1979. This definition has become accepted widely by health care professionals and researchers in the pain field and adopted by several professional, governmental, and nongovernmental organizations, including the World Health Organization. In recent years, some in the field have reasoned that advances in our understanding of pain warrant a reevaluation of the definition and have proposed modifications. Therefore, in 2018, the IASP formed a 14-member, multinational Presidential Task Force comprising individuals with broad expertise in clinical and basic science related to pain, to evaluate the current definition and accompanying note and recommend whether they should be retained or changed. This review provides a synopsis of the critical concepts, the analysis of comments from the IASP membership and public, and the committee's final recommendations for revisions to the definition and notes, which were discussed over a 2-year period. The task force ultimately recommended that the definition of pain be revised to "An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage," and that the accompanying notes be updated to a bulleted list that included the etymology. The revised definition and notes were unanimously accepted by the IASP Council early this year.
1,432 citations
••
TL;DR: Prophylactic eradication of H pylori after endoscopic resection of early gastric cancer should be used to prevent the development of metachronous gastric carcinoma.
1,066 citations
Authors
Showing all 3791 results
Name | H-index | Papers | Citations |
---|---|---|---|
Kenneth M. Yamada | 139 | 446 | 72136 |
Dietger Niederwieser | 97 | 727 | 44324 |
Naoyuki Taniguchi | 96 | 848 | 37506 |
Ulf Lindahl | 92 | 268 | 28407 |
Gen Sobue | 91 | 947 | 36378 |
Koji Kimata | 87 | 324 | 20971 |
Ryuzo Ueda | 87 | 589 | 27813 |
Akiko Tamakoshi | 80 | 589 | 24019 |
Teizo Fujita | 72 | 229 | 16680 |
Ryosuke Takahashi | 70 | 671 | 25126 |
Yasuhiro Kodera | 69 | 850 | 19442 |
Reiji Kannagi | 68 | 318 | 16642 |
Naoki Ishiguro | 68 | 868 | 19840 |
Masashi Akiyama | 65 | 685 | 16404 |
Yasuo Morishima | 65 | 418 | 16263 |